This fits well with a previous study proving the relevance of serum- and glucocorticoid-regulated kinase 1 (SGK1) for Th17 promotion during Ang-II-induced endothelial dysfunction and renal injury [14], since SGK1 itself is a Hippo pathway target gene. This evidence concerns the gene SGK1 and endothelial dysfunction.